MD serves as Consultant for Amgen, Celgene, Janssen, Kite Pharma, lava therapeutics, and Roche/Genentech. CH receives research funding from Bristol-Myers Squibb, Celgene, and Cellularity and is a Consultant for Celgene, Imbrium, Janssen, Karyopharm, Nektar, Oncopeptides, and Sanofi Pasteur. JK receives research funding from Abbvie/Genentech, Amgen, Bristol-Myers Squibb, Gelgene, Fortis Therapeutics, Janssen, Merck, and Sutro Biopharm, Inc and is a Consultant for Amgen, Bristol-Myers Squibb, Celgene, Janssen, Karyopharm Therapetuics, Sanofi, Takeda, Ecnofarma, and TG Therapeutics. SL receives research funding from Bristol-Myers Squibb, Celgene, and Takeda. He is a Consultant for Abbvie, Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Juno Therapeutics, Merck, Novartis, and Takeda. KM has served as Consultant for Janssen. AN receives research funding from Amgen, Janssen, and Takeda. He is a Consultant for Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Oncopeptides, Sanofi Pharmaceuticals, and Takeda.